These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32721136)

  • 21. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
    Johnson SW; Brown SV; Priest DH
    Clin Infect Dis; 2020 Aug; 71(5):1133-1139. PubMed ID: 31560051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile Infection Following Spine Surgery: Incidence, Risk Factors, and Association With Preoperative Antibiotic Use.
    Bell J; Vatani J; Raad M; Labaran L; Puvanesarajah V; Hassanzadeh H
    Spine (Phila Pa 1976); 2020 Nov; 45(22):1572-1579. PubMed ID: 32756273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
    Alnimr A; Alwazzeh MJ; Al-Ameer A
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring Clostridium difficile infection in an acute hospital: prevalence or incidence studies?
    Lavan AH; McCartan DP; Downes MM; Hill AD; Fitzpatrick F
    Ir J Med Sci; 2012 Sep; 181(3):315-20. PubMed ID: 22350440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice.
    Søes LM; Holt HM; Böttiger B; Nielsen HV; Torpdahl M; Nielsen EM; Ethelberg S; Mølbak K; Andreasen V; Kemp M; Olsen KE
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):957-67. PubMed ID: 24352841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study.
    Larrainzar-Coghen T; Rodríguez-Pardo D; Barba P; Aguilar-Company J; Rodríguez V; Roig G; Ferrer C; Ruiz-Camps I; Almirante B
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2075-2082. PubMed ID: 30073433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild or Malign: Clinical Characteristics and Outcomes of Clostridium difficile Infection in Thailand.
    Imwattana K; Putsathit P; Leepattarakit T; Kiratisin P; Riley TV
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI).
    Manthey CF; Dranova D; Christner M; Drolz A; Kluge S; Lohse AW; Fuhrmann V
    Crit Care; 2019 Dec; 23(1):399. PubMed ID: 31815650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis.
    Ingle M; Deshmukh A; Desai D; Abraham P; Joshi A; Rodrigues C; Mankeshwar R
    Indian J Gastroenterol; 2011 Mar; 30(2):89-93. PubMed ID: 21553102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study.
    Kim YS; Han DS; Kim YH; Kim WH; Kim JS; Kim HS; Kim HS; Park YS; Song HJ; Shin SJ; Yang SK; Ye BD; Eun CS; Lee KM; Lee SH; Jang BI; Jung SA; Cheon JH; Choi CH; Huh KC
    Epidemiol Infect; 2013 Jan; 141(1):189-94. PubMed ID: 22717061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
    Li Y; Qian J; Queener E; Shen B
    Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile infection among kidney transplant recipients: frequency, clinical presentation, and outcome.
    Lionaki S; Panagiotellis K; Moris D; Daikos G; Psyhogiou M; Vernadakis S; Zavos G; Boletis JN
    APMIS; 2015 Mar; 123(3):234-9. PubMed ID: 25556694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile infection and inflammatory bowel disease: what gastroenterologists and surgeons should know.
    Cojocariu C; Trifan A; Stoica O; Chihaia CA; Stanciu C
    Chirurgia (Bucur); 2014; 109(5):579-83. PubMed ID: 25532244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection.
    Misawa K; Iketani O; Enoki Y; Taguchi K; Uno S; Uwamino Y; Hasegawa N; Matsumoto K
    J Infect Chemother; 2021 Oct; 27(10):1407-1412. PubMed ID: 34023223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections.
    Taori SK; Wroe A; Hardie A; Gibb AP; Poxton IR
    J Infect; 2014 Aug; 69(2):134-44. PubMed ID: 24780765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
    Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
    Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients.
    Abu-Sbeih H; Choi K; Tran CN; Wang X; Lum P; Shuttlesworth G; Stroehlein JR; Okhuysen PC; Wang Y
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):128-134. PubMed ID: 30339561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.